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Oxidative damage and chemokine
production dominate days before immune
cell infiltration and EAE disease debut
Henrik Hasseldam*, Rune Skovgaard Rasmussen and Flemming Fryd Johansen
Abstract
Background: Multiple sclerosis is widely accepted as an inflammatory disease. However, studies indicate that
degenerative processes in the CNS occur prior to inflammation. In the widely used animal model
experimental autoimmune encephalomyelitis (EAE), we investigated the significance of degenerative processes
from mitochondrial membrane potentials, reactive oxidative species, cell death markers, chemokines, and
inflammatory cell types in brain, spinal cord, and optic nerve tissue during the effector phase of the disease,
before clinical disease was evident.
Methods: Sixty-two rats were placed in eight groups, n = 6 to 10. Four groups were immunized with spinal
cord homogenate emulsified in complete Freund’s adjuvant (one served as EAE group), three groups were
immunized with complete Freund’s adjuvant only, and a control group was injected with phosphate buffered
saline only. Groups were sacrificed 3, 5, 7, or 12–13 days after the intervention and analyzed for early signs of CNS
degeneration.
Results: Loss of mitochondrial membrane potential and oxidative changes was observed days before clinical disease
debut at day 9.75 ± 0.89. The early mitochondrial changes were not associated with cytochrome C release, cleavage of
caspases 9 (38/40 kDa) and 3 (17/19 kDa), and cleavage of PARP (89 kDa) or spectrin (120/150 kDa), and apoptosis was
not initiated. Axonal degeneration was only present at disease onset. Increases in a range of cytokines and chemokines
were observed systemically as a consequence of immunization with complete Freund’s adjuvant, whereas the
encephalitogenic emulsion induced an upregulation of the chemokines Ccl2, Ccl20, and Cxcl1, specifically in brain
tissue, 7 days after immunization.
Conclusion: Five to seven days after immunization, subtle decreases in the mitochondrial membrane potential
and an increased reactive oxygen species burden in brain tissue were observed. No cell death was detected at
these time-points, but a specific expression pattern of chemokines indicates activity in the CNS, several days
before clinical disease debut.
Keywords: Experimental autoimmune encephalomyelitis, Neuronal degeneration, Chemokines, Reactive oxygen
species, CNS inflammation
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Background
Multiple sclerosis (MS) is widely accepted as an inflam-
matory disease with a primary autoimmune component.
The immune system plays a central role in the patho-
genesis of the disease but the etiology remains unknown
[1]. In the clinic and according to the Revised McDonald
Criteria, a diagnosis of MS may be supported by optical
coherence tomography to detect early optic neuritis,
magnetic resonance imaging for observation of multiple
central nervous system (CNS) areas with neuronal dam-
age, a cerebrospinal fluid analysis to investigate presence
of non-specific inflammation markers, and visual evoked
potentials to examine brain processing speed, although
ultimately the diagnosis is a clinical diagnosis [2]. High
doses of intravenous corticosteroids like methylpredniso-
lone may be used for short-term treatment of symptoms,
while long-term treatment include interferon (beta-1b
or 1a), glatiramer acetate, natalizumab, and newer ther-
apeutics like dimethylfumarate, teriflunomide, and fin-
golimod [3]. Common to these long-term treatment
regimens is that the earlier they are administered to
the patients, the more effective they are. Thus, early
diagnosis is paramount in order to provide optimal
treatment, thereby implicating a need to establish reli-
able translational experimental models for MS disease
induction.
Although experimental autoimmune encephalomyelitis
(EAE) is the most frequently used model for MS, EAE
has several caveats compared to MS. One major differ-
ence is that EAE is induced by active immunization with
CNS antigens, whereas the reason behind MS seems to
be an interplay between genetic and environmental factors
[4]. In addition, plaque composition and inflammatory cell
types also differ between EAE and MS. Whereas EAE is
driven primarily by CD4+ T cells, MS infiltrates also
contain a high number of CD8+ T cells [5]. Investigators
should be cautious of assuming a direct parallel when
comparing EAE and MS.
Because EAE is an active immunization with myelin an-
tigens, the general dogma is that disease induction re-
quires the presence of activated encephalitogenic T cells in
the CNS. Thus, it is puzzling that several studies have
shown neural degeneration and death at stages in disease
development where no inflammatory cells are present in
the CNS. Investigators have found apoptosis in retinal
ganglion cells as early as 5 days after immunization [6],
whereas others report that mitochondria-derived oxidative
stress 3 days after immunization results in oligodendrocy-
tic and neuronal apoptosis [7]. Furthermore, administra-
tion of the anti-oxidant SOD2 has been shown to reduce
tissue damage significantly, suggesting a causal relation-
ship between oxidative stress and neural cell death [8]. In
addition, axonal degeneration and loss has been shown to
occur 7 days post-immunization, several days prior to
inflammatory infiltration, myelin destruction, and clinical
disease debut [9, 10]. Taken together, these papers indicate
that axonal loss in EAE may precede inflammation and
demyelination, partially mediated by oxidative stress. Pro-
viding further light to the etiology of multiple sclerosis, re-
cent findings indicate that blood-brain barrier disruption
may be one of the earliest symptoms leading to MS, where
fibrinogen enters the CNS and leads to formation of in-
soluble fibrin, increased thrombin activity, activation of in-
nate immunity, and inflammatory demyelination [11–13].
In order to further investigate and systematically
characterize events prior to inflammation and demye-
lination, we induced EAE in the Dark Agouti rat strain
using spinal cord homogenate emulsified in complete
Freund’s adjuvant (CFA) resulting in 100 % disease inci-
dence. The brain, spinal cord, cerebrospinal fluid, and
peripheral blood were isolated after immunization and
analyzed for early signs of degeneration in the form of
oxidative damage, neuronal and glial apoptosis and ne-
crosis, and cytokine and chemokine production, as well
as inflammatory infiltration.
Methods
Animals
Female Dark Agouti rats (10–12 weeks old, Harlan,
Boxmeer, The Netherlands) were housed three per cage
in conventional cages with free access to food and water
on 12-h light/dark cyclus. All animal procedures were
conducted in accordance with the guidelines of the Danish
Animal Experiments Committee (#2012-DY-2934-00001)
and the Department of Experimental Medicine, University
of Copenhagen.
EAE induction
In order to induce EAE, the animals were immunized by
subcutaneously injecting 150 μl emulsification consisting
of spinal cord homogenate in phosphate buffered saline
(PBS) (1:2; v/w) and CFA (1:1; v/v), at the tail root. Pre-
vious studies have shown that this immunization regi-
men results in 100 % disease induction [14, 15]. CFA
controls were immunized with the same amount of
emulsion without the spinal cord homogenate, whereas
the PBS animals were injected with PBS only. During
this procedure, the animals were anesthetized using 3 %
isoflurane in a mixture of O2 and N2O (2:1). Immuniza-
tions were conducted completely randomized in order
to minimize cage, experimental, and seasonal variability.
Experimental groups
A total of eight experimental groups were included in
the study. One PBS group (n = 6) sacrificed 5 days
post-injection; three CFA groups sacrificed 3 (CFA 3,
n = 6), 5 (CFA 5, n = 8), and 7 (CFA 7, n = 8) days post-
immunization (DPI); three spinal cord homogenate +
Hasseldam et al. Journal of Neuroinflammation  (2016) 13:246 Page 2 of 11
CFA groups sacrificed 3 (3 DPI, n = 8), 5 (5 DPI, n = 10), 7
(7 DPI, n = 10), and 12–13 (EAE, n = 6) DPI. EAE animals
were scored on a daily basis for clinical disease symptoms
according to the EAE clinical scoring system (0: no clinical
symptoms to 6: moribund or dead) devised by the Danish
Animal Experiments Inspectorate. When the scores
reached 2, animals were provided with food and water-gel
at the bottom of the cage. If the animals reached a score
above 4, or if weight loss exceeded 20 %, the animals were
euthanized.
Tissue preparation
After the animal was removed from the stereotaxic
frame, still under anesthesia, the femoral vein was ex-
posed and a catheter inserted. Blood was withdrawn
into heparinized micro-centrifuge tubes, centrifuged at
400×g for 8 min, and the aspirated plasma layer stored
at −80 °C for later analysis. The cell pellet was resus-
pended in red blood cell lysis buffer (Biolegend, California,
USA), incubated on ice for 5 min, centrifuged (400×g,
8 min), and frozen. The animals were perfused with
100 ml ice-cold PBS, pH = 7.2, and decapitated under
deep isoflurane anesthesia.
One random brain hemisphere was frozen in isopen-
tane and stored at −80 °C and the other processed for
mitochondrial isolation (see below).
Pieces of tissue from the cervical, thoracic, and lumbar/
sacral regions of the spinal cord were frozen in isopentane
and stored at −80 °C, processed for mitochondrial isola-
tion, or frozen in isopentane at −80 °C, and embedded in
Tissue-Tek® O.C.T. compound (Sakura Finetek, Alphen
Aan Den Rijn, The Netherlands) for cutting. The right
liver lobe was frozen in isopentane and stored at −80 °C.
The optic nerve was frozen in isopentane at −80 °C and
embedded in Tissue-Tek® O.C.T. compound (Sakura Fine-
tek) for sectioning.
Quantification of mitochondrial membrane potential
No more than 1 h after isolation, the brain and spinal
cord were processed for mitochondrial isolation and
analysis. In a Dounce homogenizer, the cells were gently
homogenized in DMEM (Thermo Fisher Scientific,
Massachusetts, USA) and the mitochondria were iso-
lated with differential centrifugation before resuspension
in respiration buffer (according to the manufacturer’s in-
structions, Mitochondria isolation kit, Sigma-Aldrich). The
mitochondrial suspension was processed immediately for
quantification of membrane potential or stored at −80 °C
for later analysis. The membrane potential in the suspen-
sion was quantified with the lipophilic cationic fluorescent
dye JC-1 (Sigma-Aldrich). The dye accumulates in the
mitochondrial matrix as a function of the electrochemical
gradient across the inner mitochondrial membrane. When
excited at 490 nm, the emission spectrum is dependent on
the concentration of JC-1. At higher concentrations, ag-
gregates will form and the fluorophore will emit at
590 nm, whereas dilute solutions will result in emission at
527 nm. After addition of JC-1, the samples were incu-
bated 10 min before measuring fluorescent intensity every
5 min for 60 min on a Fluostar Optima (BMG Labtech,
Offenburg, Germany). The 590:525 nm ratio was used to
assess the mitochondrial membrane potential where a de-
crease indicates mitochondrial depolarization. Control
runs were always performed to test the specificity of the
assay, by the addition of valinomycin, a K+-specific trans-
porter which results in complete dissipation of the mem-
brane potential (Sigma-Aldrich).
Immunohistochemistry
The embedded spinal cord and optic nerve were cut into
10-μm sections on a Leica CM 3000 cryostat (Leica
Microsystems, Wetzlar, Germany). For detection of 8-
hydroxydeoxyguanosine (8-OHdG), a modified base gen-
erated due to reactions with hydroxyl radicals, the tissue
sections were fixed in acetone for 2 × 10 min. This was
followed by incubation in 2 M HCl for 10 min to denature
the double-stranded helix and then proteinase K treat-
ment (10 μg/ml) for 8 min to remove DNA-associated
proteins. After blocking in 5 % goat serum, the sections
were incubated with the anti-8-OHdG antibody (1:300,
Abcam, Cambridge, UK) overnight at 4 °C. Following in-
cubation with chromeo 546-conjugated goat anti-mouse
antibody (1:600) for 1 h, the sections were mounted with
Vectashield mounting medium with DAPI (Vector Labs,
Burlingame, California, USA). Positive “spots” in two rep-
resentative areas each from the white and gray matter in
the spinal cord, as well as the entire optic nerve cross sec-
tion were identified. They were given a score from 1 to 3
according to size, and the total sum is given for each
group. Only spots coinciding with DAPI staining (about
90 %) were included in the quantification. The counting
was performed blinded using the Axiovert 200M LSM
520 and the software LSM 510 META (Carl Zeiss,
Oberkochen, Germany). Spinal cord cross sections were
furthermore stained with Luxol fast blue and cresyl vio-
let in order to detect demyelination. Briefly, 16 sections
from each of the PBS, CFA 7, 3 dpi, 7 dpi, and EAE ani-
mals were stained overnight at 57 °C in 0.1 % Luxol fast
blue. After washing, the staining was differentiated in
0.05 % lithium carbonate for 30 s, followed by washing
and staining in 0.1 % cresyl violet for 10 min. After dif-
ferentiation in 95 % ethanol, the sections were mounted
in CC/Mount (Sigma-Aldrich) and the staining was an-
alyzed using a Leica DMRBE microscope (Leica Micro-
systems). In addition, 16 sections from each of the
same groups as mentioned above were stained with
anti-CD3 antibody (1:100, Abcam). Briefly, the sections
were blocked with 5 % goat serum for 30 min, followed
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by incubation overnight with the primary antibody. After
washing, the sections were incubated with biotinylated goat
anti-rabbit antibody (1:500, Dako, Glostrup, Denmark) for
1 h, followed by washing and incubation with ABC com-
plex (avidin/biotin-peroxidase, Vectorlabs, California, USA)
according to the manufacturer’s instructions. After thor-
ough washing, incubation with DAB for 5 min was followed
by mounting in CC/Mount (Sigma-Aldrich). Identification
of CD3+ cells was performed blinded on a Leica DMRBE
microscope (Leica Microsystems).
Semi-quantitative determination of reactive oxygen/
nitrogen species-induced degeneration
For western blotting, the brain, spinal cord, and liver
were homogenized in RIPA buffer (200 mg tissue/ml
buffer: 25 mM Tris HCl, pH 7.6; 150 mM NaCl; 1 %
NP-40; 1 % sodium deoxycholate; 0.1 % SDS) including
a cocktail of protease inhibitors (Complete mini, Roche,
Penzberg, Germany) using a Dounce homogenizer. After
centrifugation (2 × 12.000×g, 20 min), total protein
determination (660 nm protein assay, Thermo Fisher
Scientific, Massachusetts, USA) was performed followed
by polyacrylamide gel electrophoresis and transfer onto
PVDF (Thermo Fisher Scientific) membranes. After
blocking, the membranes were probed with antibodies
against carbonylated amino acid side chains (Oxyblot
detection kit, Millipore, Massachusetts, USA), nitrated
tyrosine residues (1:1000, Abcam), cleaved caspase 3
(17/19 kDa, 1:1000, Cell Signaling Technology (CST),
Massachusetts, USA), cleaved caspase 9 (38/40 kDa,
1:1000, CST), cleaved PARP (89 kDa, 1:1000, CST),
calpain-1 large subunit (75/80 kDa, CST), cleaved
alpha-II spectrin (150/120 kDa, 1:1000, CST), non-
phosphorylated Neurofilament Heavy (NF-H, 200/180 kDa,
1:1000, Abcam), and α-tubulin (1:2500, Abcam). Primary
antibody incubations were followed by HRP-coupled anti-
IgG antibody (anti-mouse and anti-rabbit, 1:20,000, Jackson
Immunoresearch, Pennsylvania, USA) incubation, ECL
(Thermo Fisher Scientific) incubation, and develop-
ment on CL-XPosure films (Thermo Fisher Scientific).
Band or whole lane intensity was quantified using the
software ImageJ, and data normalized to α-tubulin.
Quantification of cytochrome C, neurofilament-H, and
chemokine/cytokine production
Determination of cytochrome C in cytoplasmic and
mitochondrial fractions was performed after mitochon-
drial isolation from the brain and spinal cord according
to the manufacturer’s instructions (Profiling ELISA kit,
Abcam).
Determination of NF-H levels in the plasma was per-
formed using ELISA (USBio, Massachusetts, USA), ac-
cording to the manufacturer’s instructions.
Determination of chemokine/cytokine levels in the
plasma and brain was done using the Bioplex multiplex
system (Biorad, California, USA) according to the manu-
facturer’s instructions.
Statistical analyses
590:520 nm ratios are given as mean values and com-
pared using the Kruskal-Wallis test followed by Dunn’s
multiple comparison test. Data obtained from the semi-
quantitative determinations of whole lane or specific
band intensity in western blots are given as mean ± SEM
and compared using one-way ANOVA followed by
Bonferroni’s multiple comparisons test. 8-OHdG in-
tensity in nuclei in optic nerve cross sections are given
as mean ± SEM and compared using Kruskal-Wallis
followed by Dunn’s multiple comparisons test. Cytokine/
chemokine, NF-H, and cytochrome C concentrations are
given as mean ± SEM and compared using one-way
ANOVA followed by Bonferroni’s multiple comparisons
test. A number of T cells and neutrophil granulocytes in
the peripheral blood and brain are compared using one-
way ANOVA followed by Bonferroni’s multiple compari-
sons test. p < 0.05 was considered statistically significant.
Results
Disease characteristics
Earlier studies in our group have shown 100 % disease
incidence following immunization with spinal cord
homogenate emulsified in CFA [16, 17]. In this study,
we also observed 100 % disease induction in the EAE
group (mean day of disease debut 9.75 ± 0.89; mean re-
lapse peak 12.50 ± 0.76; mean clinical score 3.50 ± 0.75,
Fig. 1a).
Mitochondrial degeneration
It is firmly established that irreversible demise of neural
cells, following exposure to various insults, is linked to a
decrease in the potential across the inner mitochondrial
membrane (Δψ m) [7, 18, 19]. This typically coincides
with the release of cytochrome C from the mitochon-
drial intramembrane space to the cytoplasm resulting in
apoptosome formation, activation of caspase 9, and in-
duction of apoptosis [20]. Therefore, we quantified Δψ m
and cytochrome C in brain and spinal cord tissue from
the animals (Fig. 1b–e).
No differences in Δψm were found between PBS, CFA 5,
and the 3 DPI animals, whereas a significant decrease—15–
19 % reduction in area under the curve—was observed in
the brain at days 5 and 7 post-immunization (Fig. 1b) and
in the spinal cord at 7 days after immunization (Fig. 1c).
This depolarization across the inner membrane could indi-
cate that the electron transport chain is compromised or
that the outer membrane is leaky, causing proton loss.
Thus, we furthermore monitored cytochrome C release to
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the cytoplasm (Fig. 1d, e). Significant loss of cytochrome C
from the mitochondria was only evident after disease debut
in the EAE animals, although we observed a tendency at
days 5 and 7 after immunization.
Oxidative changes in the brain, spinal cord, and optic nerve
It is known that disturbances in Δψ m are intimately in-
volved in redox homeostasis within the cell [21].
Therefore, we next monitored the level of oxidation in
snap-frozen homogenates from the brain and spinal
cord as well as cryosectioned optic nerves. We did that
by estimating the amount of protein carbonylation as a
marker for reactive oxygen species-induced modifica-
tions of amino acid side chains, nitrotyrosine as a
marker for peroxynitrite-mediated nitration, and 8-
OHdG as a marker for oxidative DNA damage (Fig. 2).
A significant increase in the amount of carbonylated
proteins was seen in brain tissue from 7 days after
immunization (2.2-fold) and EAE animals (2.6-fold)
(Fig. 2b). This coincides with the early decrease in Δψm,
probably reflecting reactive oxygen species-induced dam-
age to components of the electron transport chain [22]. In
contrast, the nitration of tyrosine residues was increased
in EAE animals only (4.6-fold, Fig. 2d).
Noteworthy amounts of 8-OHdG, a modified base that
serves as a marker for oxidative modifications in DNA in-
duced by the hydroxyl radical (•OH), were seen in all
groups, probably owing to atmospheric exposure (Fig. 2g).
A tendency towards an increase was seen in the spinal
cord from the 7 DPI animals (p < 0.078), whereas signifi-
cant increases were seen in both the spinal cord and optic
nerve in EAE (~2.6-fold upregulation compared to the
CFA 7 animals). Thus, oxidative stress seems to be
Fig. 1 Disease curve of the EAE animals and determination of Δψ m and cytochrome C release in the brain and spinal cord. The EAE animals
were sacrificed between days 11 and 13, all with a clinical score ≥3 (a). The mitochondrial membrane potential was monitored continuously
every 3 min, for 60 min, in the brain (b) and spinal cord (c) isolates. The ratio was significantly higher in the PBS and the CFA 5 groups compared
to the 5 and 7 DPI groups in both the brain and spinal cord (mean ± SEM, (p < 0.01). Loss of cytochrome C from the mitochondrial to the cytoplasmic
fraction in the brain (d) and spinal cord (e) was only significant in the EAE group, whereas the 7 dpi group showed a tendency (p < 0.059) towards
decreased amounts in the mitochondrial fraction, compared to the CFA 7 group. n = 5 in each group in d and e (data are presented as mean ± SEM,
*p < 0.05, **p < 0.01)
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involved in the earliest neurodegenerative events, primar-
ily affecting the brain.
Degeneration and cell death
It is known that mitochondria are intimately involved in
the control of apoptotic pathways in neural degeneration
[7, 19, 23]. Therefore, we went on to investigate whether
the mitochondrial depolarization and the increased
oxidative stress early after immunization could result in
activation of apoptotic and/or necrotic markers. We
probed the membranes with antibodies against cleaved
caspase 9 (40 and 38 kDa), cleaved caspase 3 (19 and
17 kDa), and cleaved PARP (89 and N-terminal frag-
ments from ~70–50 kDa), as well as cleaved alpha-II
spectrin (150 and 120 kDa) (Fig. 3).
Neither caspase 9, caspase 3, nor PARP (89 kDa)
showed evidence of apoptotic activity before disease was
evident (Fig. 3a–c). Thus, the attenuated Δψm observed at
pre-EAE time-points, with probable dire consequences for
the bio-energetic function of the organelle, does not seem
Fig. 2 Semi-quantitative determination of oxidative stress in the brain, spinal cord, and optic nerve. b Semi-quantification of whole lane carbonylation
(mean ± SEM) in the brain (n = 6–7/group), spinal cord (n = 6–8/group), and liver (reference tissue, n = 4/group), as exemplified in a.
d Semi-quantitative determination of whole lane nitrosylation (mean ± SEM) in the brain (n = 5/group) and spinal cord (n = 5/group), as
exemplified in c. g Mean score ± SEM of 8-OHdG positivity in spinal cord gray matter sections (n = 14–50/group) white matter sections
(n = 14–50/group, quantified regions are shown in e, scale bar 500 μm), and optic nerve sections (n = 14–40/group), exemplified in f (8-OHdG: red,
DAPI: blue, scale bar 50 μm). Examples of 8-OHdG positive “spots” scored 1, 2, and 3, respectively, are shown below. A significant upregulation of
protein carbonylation in the brain was seen already 7 days after immunization, whereas tyrosine nitration and formation of 8-OHdG was increased in
diseased animals only. Immunization had no impact on protein oxidation in liver tissue. *p < 0.05, **p < 0.01, ***p < 0.001
Hasseldam et al. Journal of Neuroinflammation  (2016) 13:246 Page 6 of 11
to be related to cytochrome C release with activation of
caspases 9 and 3 and subsequent 89 kDa PARP fragmenta-
tion. In EAE animals, the apoptotic machinery is activated
both in the brain and spinal cord due to both neural and
leukocytic death. However, cleavage of PARP into several
alternative fragments at around 55, 64, and 68 kDa oc-
curred in the 7 DPI animals as well as the EAE animals
(Fig. 3c). Proteases other than caspase 3 are known to
cleave PARP into fragments of various sizes, and the pat-
tern observed here could indicate calpain-1 activity [24].
This, together with the fact that a decrease in Δψ m is
known to be associated with necrotic cell death as well
[25], prompted us to look at the cleavage pattern of the
calpain-1 substrate alpha-II spectrin. However, spectrin
cleavage into 120- and 150-kDa fragments, known to be
present during apoptosis as well [26], was only observed
in the diseased animals (Fig. 3d).
In order to clarify whether any neurodegenerative pro-
cesses take place before inflammatory cell infiltration,
we determined the levels of a dephosphorylated epitope
in NF-H (Fig. 4a), shown to be associated with early
axonal degeneration [27]. In addition, we also tested
whether we could detect NF-H in the plasma as a
marker of axonal destruction (Fig. 4b). However, degen-
eration and cleavage of axons, with subsequent release
of axonal components to plasma, were only detectable
in the EAE animals.
Inflammatory responses in the brain and peripheral blood
Next we wanted to investigate whether an inflammatory
response in the CNS could be a causal factor behind the
subtle degenerations seen at day 7 post-immunization.
Presence of T cells (Fig. 5a) and a panel of chemokines/
cytokines (Fig. 5c, d) were analyzed at early time-points
Fig. 3 Semi-quantitative determination of cleaved caspase 9, cleaved caspase 3, cleaved PARP, and cleaved alpha-II spectrin in the brain and
spinal cord. The apoptotic markers cleaved caspase 9 (a, n = 6/group), cleaved caspase 3 (b, n = 6/group), and cleaved PARP (89 kDa, c, n = 6/
group) are increased in EAE animals only. The N-terminal PARP fragments (55 and 68 kDa, c) are upregulated in 7 DPI animals also. Cleaved
alpha-II spectrin (d, n = 6/group) is increased in EAE animals only. α-Tubulin is included as loading control. Mean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001 compared to CFA 7 animals
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after immunization. We furthermore stained for myelin
in spinal cord cross sections (Fig. 5b) to determine
whether any early demyelination was occurring.
We were not able to detect any CD3+ T cells in spinal
cord tissue before disease was evident clinically (Fig 5a).
Furthermore, no demyelination was detected in pre-
disease animals (Fig. 5b).
Given that no significant CNS influx of immune cells
occurs at 7 dpi, the mitochondrial (Fig. 1b) and oxidative
(Fig. 2b) alterations observed are probably caused by fac-
tors unrelated to direct immune cell cytotoxicity.
In the plasma, the concentration of several chemo-
kines/cytokines significantly increased as a consequence
of immunization with both CFA and with spinal cord
homogenate + CFA, compared to the PBS group (Fig. 5c).
With regard to IFN-γ and IL-17, the increase was po-
tentiated when spinal cord homogenate was present,
pointing towards their role as effector cytokines in
EAE. IFN-γ increased from 137 pg/ml in the CFA 7 an-
imals to 1302 pg/ml in the 7 DPI animals and 890 pg/
ml in the EAE animals. IL-17 went from 50 pg/ml in
the CFA 7 animals to 816 pg/ml in the 7 DPI animals
and 836 pg/ml in the EAE animals.
In the brain, a more tightly regulated response was
seen (Fig. 5d), especially with regard to the chemokines
Cxcl1, Ccl2, and Ccl20, which were highly upregulated
already in the 7 DPI animals, indicating that specific
homing to the CNS occurs after administration of an en-
cephalitogenic emulsion. At this time-point, no or very
few inflammatory cells have infiltrated the CNS, thus
signifying that these chemoattractants are produced by
non-infiltrating immune cells very early during disease
development, as indicated by a previous study [28]. Fur-
thermore, significantly increased levels of IFN-γ, IL-17,
and GM-CSF were seen in the EAE group (Fig. 5d), as
shown previously [23].
Discussion
This study investigated the significance of a range of de-
generative processes including changes in mitochondrial
membrane potentials, redox levels, and cell death
markers, as well as T cells and mediators in brain, spinal
cord, and optic nerve tissue, in pre-disease stages of
EAE. We found subtle decreases in the mitochondrial
membrane potential, coupled with an increased reactive
oxygen species burden in brain tissue at 5–7 days after
immunization. This was associated with a specific ex-
pression pattern involving the chemokines Ccl2, Ccl20,
and Cxcl1. Degenerative processes at late time-points in-
cluded increased oxidative stress and PARP fragmenta-
tion at day 7 after immunization, but these events did
not trigger caspase-mediated or necrotic cell death.
Thus, neural degeneration and cell death are either ab-
sent or below our threshold of detection, before disease
activity is present.
Early degenerative changes specifically related to mito-
chondria in EAE have been reported, and this organelle
is known to be involved in both early and late phases of
cell death [19, 25]. Already 3 days after immunization,
investigators have observed reductions in Δψ m and in-
creases in both nitrative stress and apoptosis [7, 8].
However, they used the cationic and lipophilic fluores-
cent probe Mitotracker Red to monitor Δψ m, which may
exhibit different properties compared to JC-1. Data indi-
cate that Mitotracker Red is sensitive to Δψ m in cultured
neurons, but insensitive in astrocytes, and moreover
seems sensitive to reactive oxygen species burden [29].
We did not detect differences in the levels of nitrated
tyrosine residues before EAE onset, in mitochondrial
isolates and whole tissue homogenates, in contrast to
previous results by other investigators [7]. However, they
detected very low levels of nitrotyrosine in the control
animals, whereas we saw several nitrated bands in the
PBS group (Figs. 1e and 2c). A possible explanation for
this discrepancy is that peroxynitrite formation and sub-
sequent nitration spontaneously occurred during the iso-
lation procedure in respiration buffer containing ATP
Fig. 4 Levels of non-phosphorylated NF-H (SMI-32) in the brain
(n = 6–9/group) and spinal cord (n = 6–8/group) and NF-H in the
plasma (n = 6–10/group). Non-phosphorylated NF-H (a) as well as
NF-H in the plasma (b) are increased in EAE animals only. α-Tubulin is
included as loading control. Mean ± SEM. *p < 0.05, **p < 0.01,
compared to the CFA 7 group
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and succinate. Nitration of key mitochondrial proteins
such as subunits of the mitochondrial respiratory chain
complexes I and IV and mitochondrial heat shock pro-
tein 70 were identified in the Qi study [7]. The nitration
and possible subsequent inactivation of these proteins
could be causally linked to the decreased mitochondrial
membrane potential we observed at 5 and 7 days post-
immunization.
Our finding, that significant loss of cytochrome C
from the mitochondria was evident only after disease de-
but in the EAE animals, indicates that activation of the
intrinsic apoptotic pathway, and thereby execution of
programmed cell death, occurs at a relatively late time-
point where inflammatory cells have entered the CNS
and disease activity is present.
Several reports have shown that axonal degeneration
precedes inflammatory and demyelinating events in
myelin-immunized EAE animals [6, 7, 9, 10]. Two stud-
ies by different investigators have shown axonal and
neuronal loss at 5 and 7 days post-immunization, re-
spectively [6, 10]. Both studies used manual counting of
retinal ganglion cells in the medial dorsal column. These
data differ from our findings, where cell death was non-
detectable before EAE onset (Fig. 4). Instead of manual
counting for detection of neuronal/axonal loss, we inves-
tigated whether caspase 9 or caspase 3 were activated,
and furthermore if NF-H could be detected in serum as
a sign of axonal degeneration [30, 31]. These investiga-
tions were negative in our model. Additionally, we did
not find changes in the levels of oxidative DNA modifi-
cations in the optic nerve after immunization. Since the
optic nerve consists of axons, running from neuronal
cell bodies located in the retina, and glial cells, the nu-
clei present belong to non-neuronal cells and degenera-
tive changes thus reflect glial cell damage.
Initially and before commencing this study, we specu-
lated that early neural degenerations could be a conse-
quence of cytokines being upregulated in the CNS
following immunization. Both MS and EAE show per-
ipheral and central immune activation orchestrated by
a plethora of mediators [32]. Administration of LPS
(Toll-like receptor 4 (TLR4) ligand) or immunization
with an emulsion containing CFA causes a systemic im-
mune activation with production of cytokines and che-
mokines. These mediators most likely interact with
cells in the CNS, e.g., microglia, through the choroid
plexus and/or by direct transport across the blood-brain
barrier [28, 33–35]. CFA exerts various effects through
stimulation of TLR2 by Mycobacterium tuberculosis
present in the adjuvant [36]. TLR2 activation results in the
production of a variety of different inflammatory media-
tors, possibly also in the circumventricular organs where
Fig. 5 Inflammatory response in CNS tissue and peripheral blood. No signs of CD3+ T cell infiltration or demyelination were seen in pre-diseased
animals, whereas the EAE animals had massive T cell infiltrates (a, scale bar 500 μm) and noduli (a, insert, scale bar 50 μm) and areas of demyelination
(b, indicated by two black rectangles, scale bar 500 μm). Concentrations of a wide variety of cytokines and chemokines in the plasma (c, n = 5–6/group)
and brain (d, n = 6/group). In the plasma, a general upregulation was seen as a consequence of immunization with CFA, compared to PBS, whereas
IFN-γ and IL-17 was increased further if spinal cord homogenate was present (7 dpi and EAE animals). In the brain, the chemokines Cxcl1, Ccl2, and
Ccl20 were all increased in the 7 dpi animals, whereas IFN-γ and IL-17 were increased in the EAE animals, compared to the CFA 7 group. Mean ± SEM.
*p < 0.05, **p < 0.01, and ***p < 0.0001 indicates data significantly different from the CFA 7 animals
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TLR2+ microglia are present [34, 37]. CFA is furthermore
known to compromise the integrity of the blood-brain
barrier [34]. Together, this results in significant increases
in the concentration of a variety of cytokines in CNS tis-
sue. The presence of significant amounts of these soluble
mediators, could also explain the atrophy and degenera-
tive changes observed distant from inflammatory infil-
trates in MS and EAE [35, 36].
As stated, we found increased expression of the che-
mokines Ccl2, Ccl20, and Cxcl1 in brain tissue, early
after disease induction. In 1995, Glabinsky et al. found
that MCP-1 (Ccl2) was non-detectable if leukocyte infil-
tration was absent, indicating that this chemokine may
enhance but never initiate inflammation [38]. This is in
contrast to our current data and results from other re-
cent investigations [13]. We have no solid explanation
for such different findings, although it should be noted
that Glabinsky et al. used a different model and mea-
sured mRNA levels instead of proteins.
In the choroid plexus, constitutive expression of Ccl20
has been shown to act as a gateway for T cells into unin-
flamed CNS, and Th17 cells preferentially express CCR6,
the receptor for Ccl20 [28]. Thus expression of Ccl20 in the
CNS plays a critical role in the entry of pro-inflammatory
Th17 cells into the CNS. Cxcl1 is known to attract neutro-
phils and has in other EAE studies been observed to peak
at pre-clinical stages [39, 40]. Furthermore, systemic levels
of this chemokine correlate with clinical disease activity
and lesion burden in MS patients [40].
Conclusions
Several days before clinical disease was present, subtle
decreases in mitochondrial membrane potential and in-
creases in reactive oxygen species was observed in brain
tissue. No cell death was detected at these time-points,
but a specific chemokine expression pattern indicates
early chemoattractant activity in the brain of immunized
animals.
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